IE
EOLS icon

Israel Englander’s Evolus EOLS Stock Holding History

Israel Englander’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,000
Closed -$154K – 6112
2025
Q3 		$154K Sell
25,000
-156,900
-86% -$1.22M ﹤0.01% 5614
2025
Q2 		$1.68M Buy
+181,900
New +$1.86M ﹤0.01% 4027
2024
Q4 		– Sell
-80,000
Closed -$1.3M – 6067
2024
Q3 		$1.3M Buy
+80,000
New +$1.12M ﹤0.01% 4061
2023
Q3 		– Sell
-100,000
Closed -$727K – 6224
2023
Q2 		$727K Buy
+100,000
New +$863K ﹤0.01% 4281

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Israel Englander's EOLS Position: Q2 2026 in Review

Israel Englander increased its Evolus (EOLS) stake by 22% in Q2 2026, buying an estimated $1.93M and bringing the position to 1,787,929 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Israel Englander first reported a position in EOLS in Q3 2018 and has held it in 27 quarters since. The position peaked at $21M in Q1 2023. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Israel Englander held 1,787,929 shares of Evolus worth $12.4M as of Q2 2026.
  • Israel Englander bought 326,770 Evolus shares in Q2 2026, an estimated $1.93M.
  • Evolus made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2068 holding.
  • Israel Englander first reported a position in Evolus in Q3 2018 and has held it in 27 quarters since.
  • Israel Englander's Evolus position peaked at $21M in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.